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neurodegenerative and neuropsychiatric disorders. The subject of this study was to
evaluate whether berberine protects against delayed neuronal cell death in organotypic
hippocampal culture (OHC) exposed to oxygen and glucose deprivation (OGD) and the cell
signaling mechanism related to its effect. Hippocampal slices were obtained from 6 to
8-days-old male Wistar rat and cultured for 14 days. Following, the cultures were exposed
for 1 h to OGD and then treated with Berberine (10 and 20 μM). After 24 h recovery,
propidium iodide (PI) uptake was analyzed and a decrease was observed in PI uptake on
OGD Ber-treated culture, which means a decrease in cellular death. Western blot analysis
showed that proteins Akt, GSK3β, ERK and JNK appear to play a role in berberine-mediated
neuroprotection. Furthermore, capase-3 activity of OGD Ber-treated culture was dimin-
ished by control level in a ﬂuorimetry assay. These ﬁndings suggest that berberine-
mediated neuroprotection after ischemia involves Akt/GSK3β/ERK 1/2 survival/apoptotic
signaling pathway as well as JNK and caspase-3 activity inhibition.
& 2014 Elsevier B.V. All rights reserved.1
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Simões Pires).1. Introduction
Cerebral ischemia is one of the leading causes of death
worldwide. The injured neurons undergo through biochem-
ical cascade that leads to cell death. Despite increasingstudies focused on mechanisms of ischemia have been
reported, the only effective treatment is thrombolysis.
However, due to its numerous limitations, only about 5% of
the patients can be selected for this treatment (Hall et al.,
2009).
b r a i n r e s e a r c h 1 5 5 7 ( 2 0 1 4 ) 2 6 – 3 3 27Berberine (Ber) is a major alkaloid isolated from medicinal
herbs such as Berberis sp., Coptidis sp. and Phellodendri sp. and
has a long history in Chinese and Indian medicines (Kulkarni
and Dhir, 2010). Studies demonstrated its multiple pharma-
cological actions, including anti-inﬂammatory effects (Wu
et al., 2012), diarrhea-treating action (Birdsall and Kelly,
1997) and glucose-lowering potential (Di Pierro et al., 2012).
Furthermore, it was reported that berberine has potent
neuroprotective effects against brain ischemia (Wang et al.,
2004; Yoo et al., 2006), Alzheimer's disease (Zhu and Qian,
2006; Ji and Shen, 2011) and brain tumor (Eom et al., 2008).
There appears to be at least two major modes of cell death
involved in ischemic neuron death, apoptosis and necrosis
(Lipton, 1999). Increasing evidence shows that apoptosis is
caused by an unbalance in signaling events, including phospha-
tidylinositide 3-kinases pathway (PI3K). The serine–threonine
kinase, Akt (also known protein kinase B), is a downstream
kinase of PI3K and becomes activated by phosphorylation of
residues Thr-308 and Ser-473. This kinase can be phosphory-
lated by PDK1 and PDK2 or by PI3K directly and plays an
important role for death/survival processes (Horn et al., 2005).
Akt mediates its anti-apoptotic effects by phosphorylating,
among others, GSK3β, Bad, NFkB and CREB (Mehta et al.,
2007). Serine–threonine kinase glycogen synthase kinase 3-β
(GSK3β) is particularly abundant in the central nervous
system and is neuron-speciﬁc and is a key regulator in
several physiological processes, such as cell cycle and apop-
tosis in neuronal cells during hypoxia. GSK3β induces cas-
pase3 activation and activates the pro-apoptotic tumor
suppressor gene, p53 (Loberg et al., 2002). Akt phosphoryla-
tion of GSK3β on Ser9 and its inactivation may mediate some
anti-apoptotic stimuli (Zhang et al., 2012). Extracellular
signal-Regulated Kinases (ERK 1/2) and stress-activated pro-
tein kinases (SAPK)/Jun amino-terminal kinases (JNK) are
members of the mitogen-activated protein kinases (MAPK)
family and are activated by a variety of environmental
stresses, inﬂammatory cytokines and growth factors. Those
signals are delivered to this cascade by small GTPases of the
Rho family (Rac, Rho, cdc42). SAPK/JNK translocates to the
nucleus where it can regulate the activity of multiple tran-
scription factors resulting in cell growth, differentiation,
survival and apoptosis (Moulin and Widmann, 2004).
Despite global cerebral ischemia suppress the continuous
blood ﬂux during the outcome; the hippocampus is one of the
most sensitive regions to the effects of the insult. Distinct
subﬁelds show differential vulnerability to cell death: the CA1
pyramidal neurons are vulnerable, whereas the granular cells
of the dentate gyrus (DG) are resistant. This differential
pattern of damage of CA1 cells versus preservation of DG
cells creates an ideal model for comparing cell death vulner-
ability in areas within the same region of the brain (Lipton,
1999; Horn et al., 2005).
The aim of this study was to verify berberine neuropro-
tective effect in organotypic hippocampal culture exposed to
oxygen and glucose deprivation, an in vitro model of cerebral
global ischemia, focusing on PI3K/Akt pathway and its con-
sequent signaling. For this purpose, cultures were treated
with different concentrations of berberine, based on the
literature, and then exposed to oxygen and glucose depriva-
tion (OGD). We analyzed the cell death/survival by propidiumiodide (PI) uptake, phosphorylation of signaling proteins and
caspase activation.2. Results
2.1. Effect of berberine treatment in organotypic
hippocampal cultures after OGD
Exposure of cultures to 10–20 μM of berberine caused a marked
decrease in cell death, as shown by the intense ﬂuorescence
due to incorporation of PI in hippocampus after 24 h of recovery
(Fig. 1A). The neuroprotection of berberine against in vitro
ischemia-induced hippocampal cell damage appeared to be
more effective at the concentration of 10 μM, which was chosen
for the following analysis. Quantiﬁcation of PI ﬂuorescence
showed that the exposure of cultures to OGD caused around
30% of damage in hippocampus after 24 h of recovery, a
signiﬁcant increase when compared to control cultures
(Fig. 1B). The damage induced by OGD was mainly observed
in CA1, CA2 and CA3 areas. Additionally, a small damage was
sometimes observed in the inner blade of the DG area, as
observed in Fig. 1A. This data conﬁrms our previous work using
the same experimental model of ischemic cell death (Valentim
et al., 2003). When cultures were exposed to berberine, 10 μM
and 20 μM, around 15–10% of decrease in PI staining was
observed, respectively, showing a statistically signiﬁcant neu-
roprotective effect when compared to OGD culture (Fig. 1B).
2.2. Phosphorylation of Akt/GSK3β signaling pathway
involved with berberine neuroprotective effect
As well established, kinase protein Akt plays a critical role to
promote neuronal survival after global brain ischemia. And,
as a downstream target, GSK3β is also involved in this type of
neuronal injury, as we previously reported (Mehta et al.,
2007). Therefore, we hypothesized that Akt pathway may be
important for Ber-mediated neuroprotective effect. To detect
the role of these signaling proteins, we performed western
blots (Fig. 2A and C). The expression of pAkt and pGSK3β from
OGD culture was signiﬁcantly decreased when compared to
control culture (Fig. 2B and D, correspondingly). As shown in
Fig. 2B and D, OGD berberine-treated cultures indicate a
signiﬁcant increase in protein Akt and GSK3β phosphoryla-
tion when compared with OGD culture. Also, OGD berberine-
treated cultures demonstrated a 2.0 fold increase in pAkt
level when compared to control culture (Fig. 2B).
2.3. ERK 1/2 activation and inhibition of JNK signaling
pathway plays a role in berberine-mediated neuroprotection
Apoptosis is involved in the ischemic cell death pathway and
can be mediated by several signaling molecules, such as pro-
apoptotic proteins BAX and Bcl-Xs (Cui et al., 2009), caspase
family (Ouyang et al., 1999; Horn et al., 2005) and cytokines
liberation (Yasuda et al., 2011; Simão et al., 2012). MAPK
family proteins such as ERK and JNK are common upstream
pathway proteins that can lead to those apoptotic responses
signaling, s study that has been demonstrated (Wang et al.,
2007). To conﬁrm the role of ERK/JNK as protein-related to
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Fig. 1 – Administration of Berberine after OGD in OHC decrease PI uptake. (A) Representative pictures of OHC slices stained
with propidium iodide after treatment with 10 and 20 μM of Ber and after 24 h recovery (magniﬁcation: 40 ). (B) PI
incorporation quantiﬁcation from pictures shown in (A). Bars represent the mean7S.E.M., n¼12. # Signiﬁcantly different from
control cultures and n signiﬁcantly different from cultures exposed to OGD alone; npo0.05 (one-way ANOVA followed by
Tukey's test).
b r a i n r e s e a r c h 1 5 5 7 ( 2 0 1 4 ) 2 6 – 3 328ischemic death and if they are involved with the berberine
neuroprotective effect, we analyzed the phosphorylation
content in the cell culture.
The ERK MAP kinase pathway was also triggered by
berberine, with clear increase (3-fold) in phospho-ERK levels
in OGD-treated slice when compared to OGD group (Fig. 3A
and B). As shown in Fig. 3C, the exposure to OGD induced an
increase of 3.29 fold on JNK phosphorylation when compared
to control culture. However when cultures were treated with
berberine, the level of JNK phosphorylation was similar to
control cultures (Fig. 3C and D).2.4. Berberine neuroprotective effect decreases caspase 3
activity
There are further chemical changes that are suggestive of
apoptosis and are expressed in vulnerable CA1 area. Induc-
tion of classical apoptosis by caspase 3 occurs in cells after
global ischemia before and during the time of maximal cell
death (Lipton, 1999). Based on that information we carried out
a ﬂuorimetry assay for the effector caspase 3. A higher
caspase activity was detected in OGD culture (Fig. 4), whereasin cultures treated with berberine a lower caspase 3 activity
was observed, which was similar to that observed in control
cultures (Fig. 4).3. Discussion
There are two major types of cerebral ischemia, focal and global.
The brain injury caused by transient global cerebral ischemia is
characterized by a delayed selective death of CA1 pyramidal
neurons in the hippocampus (Kirino, 1982; Lipton, 1999). This
region is critically involved in spatial learning and memory, and
the degeneration of pyramidal neurons results in impairment of
these functions (Bendel et al., 2005, Frozza et al., 2013). One of the
principal features of OHC is to keep the tissue organization as
in vivo: the slice presents all types and organized cells as in the
in vivo form. This experimental model of brain ischemia has a
great advantage over others cultures since they retain several
global brain ischemia in vivo aspects, such as delayed neuronal
death and selective vulnerability (Strasser and Fischer, 1995;
Noraberg et al., 1999, 2005; Zamin et al., 2006).
The present study provides evidence that berberine
addition to the culture medium of hippocampal organotypic
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Fig. 2 – Berberine enhances Akt and GSK3β phosphorylation. Representative western blots showing levels of pAkt, Akt (A) and
pGSK3β, GSK3β (C) in OHC culture. The average levels of pAkt (B) and pGSK3β (D) were increased in OGD Berberine-treated
culture after 24 h recovery. Bars represent the mean7S.E.M., n¼7/6. # Signiﬁcantly different from control cultures and
n signiﬁcantly different from cultures exposed to OGD alone; po0.05 (one-way ANOVA followed by Tukey's test).
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Fig. 3 – Berberine induces regulation on MAP kinase pathway as indicated by elevated pERK 1/2 and decrease in pJNK levels in
OGD-treated culture. (A–C) Representative western blots showing levels of pERK 1/2, ERK, pJNK and JNK in OHC culture. The
average levels of pERK 1/2 were increased (B) and decreased (D) in OGD Berberine-treated culture after 24 h recovery. Bars
represent the mean7S.E.M., n¼6. # Signiﬁcantly different from control cultures and n signiﬁcantly different from cultures
exposed to OGD alone; po0.05 (one-way ANOVA followed by Tukey's test).
b r a i n r e s e a r c h 1 5 5 7 ( 2 0 1 4 ) 2 6 – 3 3 29culture, after OGD exposition, an in vitro model of brain
ischemia, has neuroprotective effect as seen by a decrease in
incorporation of dye propidium iodide; and this effect appears
to be mediated via modulation of cellular signaling PI3K/Aktand JNK, leading to decreased activation of caspase 3, involved
in mediation of apoptotic cell death.
Studies have demonstrated potential cell protective
mechanisms of berberine on cerebral ischemia such as
Control Control Ber 10 μM OGD OGD + Ber 10 μM
0
200
400
600
#
*
C
as
pa
se
 3
 a
ct
iv
ity
 (%
 o
f c
on
tro
l)
Fig. 4 – Lower caspase-3 activity following global ischemia
after Ber treatment.Caspase-3 activity in OHC with Ber
administration after OGD and 24 h recovery. Bars represent
the mean7S.E.M., n¼6. # Signiﬁcantly different from control
cultures and n signiﬁcantly different from cultures exposed
to OGD alone; po0.05 (one-way ANOVA followed by
Tukey's test).
b r a i n r e s e a r c h 1 5 5 7 ( 2 0 1 4 ) 2 6 – 3 330involvement of Akt, GSK3β, CREB on cerebral cortex in an
in vivo rat model of permanent middle cerebral artery occlu-
sion (pMCAO) (Zhang et al., 2012) and Bcl-2 (Cui et al., 2009),
cytochrome C release (Zhou et al., 2008) in mouse OHC and
PC12 cell OGD model. Akt is well known to be the primary
basis of neuronal survival and prevents the progression of
apoptotic stimuli after brain ischemia outcome. These ﬁnding
is conﬁrmed with the use of Akt inhibitor LY294002on brain
ischemic model (Horn et al., 2005). In the present work, our
results suggest that the Akt phosphorylation acts on the
berberine-mediated neuroprotective effect and contributes
to hippocampal cell survival and thus suppresses apoptosis.
The targets of the protein Akt are many and varied, but all
of them are related to cell proliferation and/or survival and
result in antiapoptotic effect. These physiological roles of Akt
include involvement in metabolism, protein synthesis, apop-
tosis pathways, transcription factor regulation and the cell
cycle. Akt exerts its effects in the cell by phosphorylating
a variety of downstream substrates, including GSK3β, Bcl-2 –
family member Bad and CREB (Downward, 1998). Our data
demonstrated an enhanced phosphorylation of GSK3β at Ser9
in OGD-berberine treated culture which blocked the protein
activation and consequently negatively regulates its pro-
apoptotic signaling. A role for GSK3β in ischemia demon-
strates the use of a GSK3β inhibitor to decrease infarct size in
rodents (Kelly et al., 2004). As our data suggest, Akt/ GSK3β
pathway is likely to be important for Ber-neuroprotective
effect, given the abundance of GSK3β on the central nervous
system and its role on ischemia.
In this study, we deﬁned the relationship between Ber and
Akt/GSK signaling, as well as ERK 1/2 and JNK in ischemic
hippocampal tissue. Members of the MAP kinase family play
crucial roles in regulating responses to various stresses, and
in neural development, inﬂammation, and apoptosis (Simão
et al., 2012). Besides stress, those signaling proteins can
also be activated via G-Protein Coupled Receptors (GPCRs),Receptor Tyrosine Kinases (RTKs) and Cytokine Receptors.
Growth Factors also activate ERK/JNKs. Although the signal-
ing cascade from Growth Factor Receptors to ERKs is rela-
tively well understood, the pathway leading to JNK activation
is more unclear (Mehta et al., 2007). Growth Factors and
Growth Factor Receptors stimulate Ras and PI3K; an Akt
upstream protein also activates Ras (Downward, 1998). Our
results demonstrated the MAP kinase pathway was for
instance shown to be involved in Berberine-mediated neuro-
protection in OGD culture. The causes of cell death in stroke
are multifactorial and are inﬂuenced by the ischemic envir-
onment lacking in nutrients and oxygen, coupled with the
loss of survival signals towards apoptosis and inﬂammation,
for example. We have started investigation on cytokine
secretion in vitro after OGD to combine with these data and
have a more detailed knowledge of JNK activation by Berber-
ine treatment. Thereby combined results and use of inhibi-
tors of the PI3K/Akt and MAPK pathways could affect more
signiﬁcantly the Berberine-mediated neuroprotection.
Apoptosis is proved to play a role in neuronal death in
human stroke and its animal models several hours after
obtaining evidence based on studies of ischemia. The activa-
tion of caspases, particularly caspase-3, and the inhibition of
cell death by inhibition of these proteases are the strongest
criteria. Caspase do not appear to be activated in necrotic
death (Lipton, 1999). The caspase cascade is activated by two
distinct routes: one from cell surface and the other from
mitochondria. The pathway leading to caspase activation
varies according to the apoptotic stimulus. Another evidence
for caspase involvement is the upregulation of the enzyme.
This occurs either by cleaving the existing procaspases or by
synthesizing a new enzyme that is then cleaved (Sugawara
et al., 2004). In this study, we showed increase of caspase-3
activation in OGD culture. After Ber treatment, the protein
activity was in the same control level. Other studies continue
in the same direction as ours: caspase-3-like mRNA is
upregulated between 8 and 24 h after 15–30-min ischemia in
rat, predominantly in CA1 pyramidal cells, and total caspase-
3 protein is increased by 8 h. And also, caspase-3-like activity
measured in artiﬁcial substrate was elevated about 10-fold in
hippocampus between 8 and 24 h after ischemia (Chen et al.,
1998).
In conclusion, we demonstrated the phosphorylation of
Akt/GSK3β pathway and the involvement of ERK 1/2, JNK and
caspase-3 inhibition after Berberine treatment of organotypic
hippocampal culture following an in vitro global brain ische-
mia model. Our study provides beneﬁcial evidences for early
administration of Berberine and its underlying mechanisms
and interrelated pathways that may rescue neuronal cells
after global brain ischemia.4. Experimental procedures
4.1. Organotypic hippocampal cultures
Organotypic hippocampal cultures were prepared according
to the method of Stoppini et al. (1991) with some modiﬁca-
tions (Valentim et al., 2003). The local Animal Care Commit-
tee approved all animal procedures used. Hippocampal slices
b r a i n r e s e a r c h 1 5 5 7 ( 2 0 1 4 ) 2 6 – 3 3 31were obtained from 6 to 8-day-old male Wistar rats by
removing the brain, dissecting hippocampi and making
transverse slices (400 μm), using a Mcllwain tissue chopper.
Slices were separated in a Hank's balanced salt solution
(HBSS) (Gibco) supplemented with 25 mM HEPES, 1% fungi-
zone and 36 μl/100 ml gentamicin, pH 7.2. Six slices were
placed on one Millicell culture insert (Millicell-CM, 0.4 μm)
and the inserts were transferred to a six-well culture plate
(Cell Culture Cluster, TPP) with 1 ml of culture medium
consisting of 50% minimum essential medium (MEM) (Gibco),
25% heat inactivated horse serum (Gibco) and 25% HBSS
(Gibco), supplemented with glucose 36 mM, glutamine
2 mM, HEPES 25 mM and NaHCO3 4 mM (ﬁnal concentrations).
Fungizone 1% and gentamicin 36 μl/100 ml were added to the
medium. The pH was adjusted to 7.3 and immediately the
solution was ﬁltered (Millex-GS, Millipore). The plates were
then placed in an incubator at 37 1C in an atmosphere of 5%
CO2. The medium was changed twice a week and experi-
ments were carried out after 14 days in vitro.
4.2. Oxygen and glucose deprivation (OGD)
The induction of OGD was based on the method described by
Strasser and Fischer (1995) with some modiﬁcations
(Cimarosti et al., 2001). Cultures were carefully rinsed three
times with OGD medium composed of CaCl2 1.26 mM, KCl
5.36 mM, NaCl 136.9 mM, H2PO4 0.34 mM, MgCl2 0.49 mM,
MgSO4 0.44 mM, HEPES 25 mM, pH 7.2. Slices were left in
1 ml of this medium for 15 min, and then the medium was
exchanged by one with the same composition previously
bubbled with nitrogen for 30 min. The cultures were trans-
ferred to an anaerobic chamber at 37 1C in which the oxygen
was replaced by nitrogen, and left in these conditions for
60 min. Slices were washed three times with HBSS and
treated with 10 and 20 μM of berberine chloride (Sigma)
diluted in water (37 1C) added to the culture medium. After-
wards, the plates were brought back to the usual culture
conditions for 24 h recovery time with the culture medium
treated with berberine.
4.3. Quantiﬁcation of cellular death
Cellular damage was assessed by ﬂuorescent image analysis
of propidium iodide (PI) uptake (Valentim et al., 2003; Horn
et al., 2005). PI 5 μM was added 1 h before the end of the
recovery period and cultures were observed with an inverted
microscope (Nikon Eclipse TE 300) using a standard rhoda-
mine ﬁlter. Images were captured and analyzed using Scion
Image software (http://www.scioncorp.com). The area where
PI ﬂuorescence was detectable above background levels was
determined using the “density slice” option of Scion Image
software and compared to the total slice area to obtain the
percentage of damage.
4.4. Western blot analysis
After obtaining ﬂuorescent images, slices were homogenized
in lyses buffer, aliquots were taken for protein determination
by Lowry assay and β-mercaptoethanol was added to a ﬁnal
concentration of 5%. Proteins were resolved (50 μg per lane)on SDS-PAGE. After electrophoresis, proteins were electro
transferred to nitrocellulose membranes using a semi-dry
transfer apparatus. Membranes were incubated for 60 min at
4 1C in blocking solution (Tris-buffered saline containing 5%
powdered milk and 0.1% Tween-20, pH 7.4) and further
incubated with the appropriate primary antibody dissolved
in the blocking solution overnight at 4 1C. Primary antibodies
anti-pAkt/Ser473 (1:1000), anti-Akt (1:1000), anti-pGSK3β/Ser9
(1:1000), anti- GSK3β (1:1000), anti-pERK 1/2/Thr202-Tyr204
(1:1000), anti-ERK 1/2 (1:1000), anti-pJNK/Thr183-Tyr185 (1:1000),
anti-JNK (1:1000) and anti-β-actin (1:1000) were used. The
membranes were then incubated with horseradish peroxi-
dase–conjugated anti-rabbit antibodies (1:1000) for 2 h. The
chemioluminescence was detected using X-ray ﬁlms that
were scanned and analyzed using the Optiquant software
(Packard Instruments). All antibodies were purchased from
Cell Signaling Technology, USA. Data are expressed as per-
centage of control cultures.4.5. Caspase activity measurement
Caspase 3 activity was measured by the cleavage of the
ﬂuorescent substrate Ac-DEVD-AFC (Sigma). The procedure
with OHC, OGD and treatment (Ber 10 μM) were the same
described above. Twenty four hours after recovery, the slices
were taken out from culture membranes and lysed in ice-cold
solution of PBS and Triton x-100 0.2%. The extract was
centrifuged at 10,000g for 5 min and the supernatant was
collected. For each experiment, 30 mg of protein was incu-
bated with a reaction buffer containing (g/ml): sucrose 0.1,
CHAPS 0.001, BSA 0.0001 and HEPES–NaOH 0.024, pH 7.5 in a
96 wells black plate. The caspase 3 substrate was present at a
ﬁnal concentration of 20 μM. The plate was incubated at 37 1C
for 10 min under agitation. Samples were assayed using
SoftMax Pro ﬂuorescence plate reader (Molecular Devicess,
USA). Data are expressed as percentage of control cultures.4.6. Statistical analysis
Data are expressed as mean7S.E.M. One-way analysis of
variance (ANOVA) was applied to the means to determine
statistical differences between experimental groups. Post hoc
comparisons were performed by Tukey's test (GraphPad
Prism software 5.0). Differences between mean values were
considered signiﬁcant when po0.05.Acknowledgments
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